Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedDec 24, 2025
DataAggregated Company Financials
Companies5
  • 7D6.9%
  • 3M-10.1%
  • 1Y-44.9%
  • YTD-46.3%

Over the last 7 days, the Pharma industry has risen 6.9%, driven by gains from Novo Nordisk of 7.2%. In the past year, the industry is down 45%. As for the next few years, earnings are expected to grow by 5.3% per annum.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 24 Dec 2025DKK 1.6tDKK 345.8bDKK 108.6b14.2x14.4x4.5x
Fri, 21 Nov 2025DKK 1.5tDKK 345.8bDKK 108.6b13.5x13.7x4.3x
Sun, 19 Oct 2025DKK 1.6tDKK 341.3bDKK 115.5b13.7x14x4.7x
Tue, 16 Sep 2025DKK 1.7tDKK 341.3bDKK 115.5b14.2x14.4x4.9x
Thu, 14 Aug 2025DKK 1.5tDKK 340.6bDKK 115.2b13x13.2x4.5x
Sat, 12 Jul 2025DKK 2.1tDKK 331.8bDKK 108.8b19.3x19.3x6.3x
Mon, 09 Jun 2025DKK 2.3tDKK 331.8bDKK 108.8b20.8x20.7x6.8x
Wed, 07 May 2025DKK 2.0tDKK 318.1bDKK 105.0b19.4x19.3x6.4x
Fri, 04 Apr 2025DKK 2.1tDKK 317.9bDKK 104.9b20.1x19.9x6.6x
Sun, 02 Mar 2025DKK 2.9tDKK 317.9bDKK 104.9b28.3x28x9.2x
Tue, 28 Jan 2025DKK 2.8tDKK 297.4bDKK 98.1b29.2x28.9x9.5x
Thu, 26 Dec 2024DKK 2.8tDKK 297.4bDKK 98.2b29.1x28.8x9.5x
Sat, 23 Nov 2024DKK 3.4tDKK 297.4bDKK 98.2b35.2x34.8x11.5x
Mon, 21 Oct 2024DKK 3.7tDKK 283.9bDKK 93.2b39.8x39.3x12.9x
Wed, 18 Sep 2024DKK 4.1tDKK 283.9bDKK 93.2b44.5x43.9x14.4x
Fri, 16 Aug 2024DKK 4.2tDKK 283.1bDKK 92.9b45.8x45.2x14.8x
Sun, 14 Jul 2024DKK 4.4tDKK 269.3bDKK 92.2b48.7x47.9x16.4x
Tue, 11 Jun 2024DKK 4.4tDKK 269.3bDKK 92.2b49.1x48.1x16.5x
Thu, 09 May 2024DKK 4.0tDKK 269.1bDKK 92.1b44.1x43.5x14.9x
Sat, 06 Apr 2024DKK 3.9tDKK 257.0bDKK 86.4b46.3x45.5x15.3x
Mon, 04 Mar 2024DKK 3.9tDKK 257.0bDKK 86.4b45.4x44.6x15x
Wed, 31 Jan 2024DKK 3.4tDKK 238.8bDKK 78.2b44.3x43.4x14.2x
Fri, 29 Dec 2023DKK 3.2tDKK 238.8bDKK 78.2b41.3x40.5x13.3x
Sun, 26 Nov 2023DKK 3.3tDKK 238.8bDKK 78.2b42.5x41.6x13.6x
Tue, 24 Oct 2023DKK 3.1tDKK 225.4bDKK 70.1b45.4x44.3x13.8x
Thu, 21 Sep 2023DKK 3.0tDKK 225.4bDKK 70.1b44.1x43.1x13.4x
Sat, 19 Aug 2023DKK 2.9tDKK 224.8bDKK 69.9b41.7x40.8x12.7x
Mon, 17 Jul 2023DKK 2.4tDKK 211.8bDKK 63.8b39x38.1x11.5x
Wed, 14 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b40x39.2x11.8x
Fri, 12 May 2023DKK 2.6tDKK 211.8bDKK 63.8b42.4x41.5x12.5x
Sun, 09 Apr 2023DKK 2.5tDKK 199.7bDKK 57.8b43.6x42.9x12.4x
Tue, 07 Mar 2023DKK 2.3tDKK 199.7bDKK 57.8b40.9x40.3x11.6x
Thu, 02 Feb 2023DKK 2.2tDKK 189.2bDKK 54.7b40.3x39.7x11.5x
Sat, 31 Dec 2022DKK 2.2tDKK 189.2bDKK 54.7b40.1x39.7x11.5x
Price to Earnings Ratio

39.7x


Total Market Cap: DKK 2.2tTotal Earnings: DKK 54.7bTotal Revenue: DKK 189.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 34.2x202320242025
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 14.4x which is lower than its 3-year average PE of 34.2x.
  • The 3-year average PS ratio of 11.0x is higher than the industry's current PS ratio of 4.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 22% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market2.81%
Healthcare5.87%
Pharma6.87%
Pharma6.87%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NOVO B Novo NordiskDKK 331.557.2%
+DKK 98.6b		-46.7%PE14.2x
ALK B ALK-AbellóDKK 227.604.3%
+DKK 2.1b		44.9%PE45.7x
STENO StenocareDKK 1.471.4%
+DKK 863.9k		11.4%PS11.2x

Latest News

ALK B
DKK 227.60
ALK-Abelló
7D
4.3%
1Y
44.9%
HLUN B
DKK 43.00
H. Lundbeck
7D
-0.2%
1Y
3.3%

HLUN B: Long Term Revenue Outlook Will Likely Weigh On Shares

Analysts have nudged their price target on H. Lundbeck up by approximately 1 currency unit to 39, citing a slightly higher projected profit margin and modestly richer future valuation multiples, even as they temper long term revenue growth expectations and apply a marginally higher discount rate.
NOVO B
DKK 331.55
Novo Nordisk
7D
7.2%
1Y
-46.7%
STENO
DKK 1.47
Stenocare
7D
1.4%
1Y
11.4%
PEG
DKK 0.094
Pharma Equity Group
7D
-7.8%
1Y
-47.6%